110 coding-"https:" "https:" "https:" "https:" "https:" "https:" "U.S" research jobs at Northeastern University
Sort by
Refine Your Search
-
biochemistry, genetics, microbiology, and cell biological approaches. For more information check the Saavedra lab website: https://www.saavedralab.com The successful candidate for this role will join a
-
, biomedicine, and other areas of societal importance. Coding and/or machine learning experiences are highly valued. Specific projects may involve developing multiscale simulation methods for quantum mechanical
-
functional supervision over graduate and undergraduate students. The appointment generally does not extend beyond two years. To learn more about the work in the group, checkout out the group website. https
-
® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is also approved for the treatment
-
medical, vision, dental, paid time off, tuition assistance, wellness & life, retirement- as well as commuting & transportation. Visit https://hr.northeastern.edu/benefits/ for more information. All
-
eligible employees. This includes medical, vision, dental, paid time off, tuition assistance, wellness & life, retirement- as well as commuting & transportation. Visit https://hr.northeastern.edu/benefits
-
https://hr.northeastern.edu/benefits/ for more information. All qualified applicants are encouraged to apply and will receive consideration for employment without regard to race, religion, color
-
BioNTech BioNTech is a Germany-based biotechnology company with U.S. offices in Cambridge, MA, Berkeley Heights, NJ and Gaithersburg, MD, that focuses on developing cancer therapeutics, including
-
the Institute for Mechanobiology (IfM) in Boston, MA (see https://mechanobiology.northeastern.edu/our-faculty for list of the IfM core faculty). This position has an initial 2-year appointment, renewable
-
for epidemiology with some coding of simulations. Tentative start date: February 2026. This work will contribute towards the understanding of disease progression and building reinforcement learning frameworks